Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-05 Sale | 2024-07-09 6:04 pm | Crinetics Pharmaceuticals Inc. | CRNX | Hassard James Chief Commercial Officer | 15,000 | $44.08 | $661,200 | 159,259 (Direct) | View |
| 2024-06-21 Sale | 2024-06-24 5:08 pm | Crinetics Pharmaceuticals Inc. | CRNX | Hassard James Chief Commercial Officer | 15,000 | $44.66 | $669,900 | 174,259 (Direct) | View |
| 2021-06-22 Sale | 2021-06-24 6:44 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hassard James Chief Commercial Officer | 3,625 | $89.22 | $323,423 | 105,750 (Direct) | View |
| 2021-01-07 Sale | 2021-01-08 6:05 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hassard James Chief Commercial Officer | 15,625 | $75 | $1,171,875 | 109,375 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-05 Exercise | 2024-07-09 6:04 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Hassard James Chief Commercial Officer | 15,000 | $19.73 | 159,259 (Direct) | View |
| 2024-07-05 Exercise | 2024-07-09 6:04 pm | N/A 2032-03-10 | Crinetics Pharmaceuticals Inc. | CRNX | Hassard James Chief Commercial Officer | 15,000 | $0 | 159,259 (Direct) | View |
| 2024-06-21 Exercise | 2024-06-24 5:08 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Hassard James Chief Commercial Officer | 15,000 | $19.73 | 174,259 (Direct) | View |
| 2024-06-21 Exercise | 2024-06-24 5:08 pm | N/A 2032-03-10 | Crinetics Pharmaceuticals Inc. | CRNX | Hassard James Chief Commercial Officer | 15,000 | $0 | 174,259 (Direct) | View |
| 2024-03-18 Tax Withholding | 2024-03-20 6:34 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Hassard James Chief Commercial Officer | 1,741 | $38.14 | 29,259 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-06 8:18 pm | N/A 2034-03-03 | Crinetics Pharmaceuticals Inc. | CRNX | Hassard James Chief Commercial Officer | 80,000 | $0 | 94,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 4:47 pm | N/A 2033-02-28 | Crinetics Pharmaceuticals Inc. | CRNX | Hassard James Chief Commercial Officer | 79,250 | $0 | 79,250 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-10 4:51 pm | N/A 2032-03-09 | Crinetics Pharmaceuticals Inc. | CRNX | Hassard James Chief Commercial Officer | 160,000 | $0 | 160,000 (Direct) | View |
Ownership | 2020-01-13 5:13 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hassard James Chief Commercial Officer | 0 | $0 | 125,000 (Direct) | View |